Intradialytic Hypertension Clinical Trial
Official title:
Blood Pressure, Endothelial Cell Dysfunction, and Outcomes in Dialysis Patients
1. To determine in a cross sectional case-controlled cohort study of 50 hemodialysis patients if blood pressure elevations with hemodialysis are associated with decreased endothelial cell function (measured by brachial artery flow mediated dilation and endothelial progenitor cell number), both of which are novel mechanistic markers in the causal pathway for detrimental cardiovascular outcomes; and 2. To determine if lowering blood pressure with carvedilol in 25 ESRD subjects with blood pressure elevations with hemodialysis can improve endothelial cell dysfunction as a surrogate mechanistic marker for improving cardiovascular outcomes.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03038165 -
Hemodynamic Parameters Changes in the Course of Hemodialysis Sessions in Patients With Intradialytic Hypertension
|
||
Completed |
NCT01371890 -
Mechanisms and Treatment of Intradialytic Hypertension - Sodium
|
||
Completed |
NCT05430438 -
Effect of Low Versus Standard Dialysate Sodium on 48h Ambulatory BP in Patients With Intradialytic Hypertension
|
N/A | |
Completed |
NCT01862497 -
Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension
|
||
Completed |
NCT01916668 -
A Cross-sectional Study on Intradialytic Hypertension at Four Haemodialysis Units in the Western Cape
|
N/A |